Patient education for early detection
Featured Products Promotional FeaturesPosted by: Dental Design 16th April 2024
With more than 744,000 cases each year worldwide and less than a 50% five-year survival rate,[i] it’s crucial that clinicians raise awareness of oral cancer.
Discussing risk factors with patients and carrying out regular checks is essential for preventing oral cancer, and detecting it in its early stages. By becoming familiar with the early symptoms, and educating patients, dentists are more likely to pick up on the signs more quickly.
Plus, if a dentist does detect a lesion, the use of a pre-diagnostic test such as the BeVigilant™ OraFusion™ system from Vigilant Biosciences® can identify the presence of biomarkers associated with oral cancer, producing a result in 15 minutes or less. The result of this test can then be used to inform further examinations and referral to a specialist.
Please contact the team for more information.
For more information, please visit https://totaltmj.co.uk/products/bevigilant-orafusion/
Call: 01202 313702 or Email: Info@totaltmj.co.uk
[i] https://vigilantbiosciences.com/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes/
